{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:53:48Z","timestamp":1787241228366,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.diagmicrobio.2013.05.019","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T10:18:38Z","timestamp":1373969918000},"page":"37-40","source":"Crossref","is-referenced-by-count":32,"title":["Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values"],"prefix":"10.1016","volume":"77","author":[{"given":"Michael A.","family":"Pfaller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Diekema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary W.","family":"Procop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0005","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1128\/JCM.00952-10","article-title":"Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study","volume":"48","author":"Borghi","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/JCM.01096-09","article-title":"Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods","volume":"48","author":"Bourgeois","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0015","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard - 3rd edition, M27-A3","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0020","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts: 3rd informational supplement (M27-S3)","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0025","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1128\/JCM.02316-09","volume":"48","author":"Cuenca-Estrella","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0030","series-title":"Manual of Clinical Microbiology","first-page":"1693","article-title":"Candida, Cryptococcus and other yeasts of medical importance","author":"Hazen","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0035","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard, 2nd ed, M27-A2","author":"National Committee for Clinical Laboratory Standards (NCCLS)","year":"2002"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0040","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/CMR.19.2.435-447.2006","article-title":"Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing","volume":"19","author":"Pfaller","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0045","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/JCM.44.3.819-826.2006","article-title":"Correlation of MIC with outcome for Candida species against voriconazole: analysis and proposal for interpretive breakpoints","volume":"44","author":"Pfaller","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0050","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1128\/JCM.01986-06","article-title":"Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp","volume":"45","author":"Pfaller","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0055","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1128\/JCM.00403-07","article-title":"Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp","volume":"45","author":"Pfaller","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0060","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1128\/JCM.01391-08","article-title":"Validation of 24-hour fluconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: results from a global Candida antifungal surveillance program","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0065","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.drup.2010.09.002","article-title":"Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods","volume":"13","author":"Pfaller","year":"2010","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12281-010-0022-x","article-title":"Wild-type MIC distributions and epidemiologic cutoff values for fluconazole and Candida: time for new clinical breakpoints?","volume":"4","author":"Pfaller","year":"2010","journal-title":"Curr Fungal Infect Rep"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0075","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/JCM.02437-10","article-title":"Validation of 24-hour posaconazole and voriconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: application of epidemiological cutoff values to results from a global Candida antifungal surveillance program","volume":"49","author":"Pfaller","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0080","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.diagmicrobio.2011.03.002","article-title":"Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiological, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria","volume":"70","author":"Pfaller","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0085","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/JCM.02161-10","article-title":"Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution","volume":"49","author":"Pfaller","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0090","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1128\/JCM.05047-11","article-title":"Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida","volume":"49","author":"Pfaller","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0095","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/JCM.00937-12","article-title":"Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0100","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1128\/JCM.02070-08","article-title":"Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata","volume":"47","author":"Posteraro","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2013.05.019_bb0105","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/jac\/dkr244","article-title":"Evaluation of antifungal therapy in patients with candidemia based on susceptibility testing results: implications for antimicrobial stewardship programs","volume":"66","author":"Shah","year":"2011","journal-title":"J Antimicrob Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889313003349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889313003349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T10:51:52Z","timestamp":1539514312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889313003349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0732889313003349"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.05.019","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}